🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase Ib/II platform clinical study to evaluate the initial effic...
Status
Not Yet Recruiting
Location
Department of Pancreatic Surgery, Fudan University Shanghai Cancer Center; Pancreatic Cancer Institute, Fudan University
Start Date
2024-04-30
Trial ID
NCT06370754
For limited-stage small cell lung cancer (SCLC), neoadjuvant chemotherapy p...
Status
Recruiting
Location
Shanghai Pulmonary Hospital
Start Date
2024-04-01
Trial ID
NCT06256237
Treatments Being Tested
The objective of this study is to evaluate the efficacy and safety of chemo...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2025-09-01
Trial ID
NCT07101614
The primary objective is to assess the safety and tolerability of TAB004 as...
Status
Unknown
Location
University of Alabama at Birmingham
Start Date
2019-10-30
Trial ID
NCT04137900
Treatments Being Tested
This is an open-label phase I study to evaluate the safety, tolerability, a...
Status
Terminated
Location
Chinese PLA General Hospital
Start Date
2022-07-28
Trial ID
NCT05427396
Treatments Being Tested
For stage III non-small cell lung cancer (NSCLC), neoadjuvant chemotherapy ...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2023-07-01
Trial ID
NCT05891080
Treatments Being Tested
This is an open-label phase I/II study to evaluate the safety, tolerability...
Status
Completed
Location
Jilin Cancer Hospital
Start Date
2021-08-27
Trial ID
NCT05000684
Treatments Being Tested
This study is A prospective，single arm, multicenter clinical study of BTLA ...
Status
Not Yet Recruiting
Location
Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine
Start Date
2025-10-30
Trial ID
NCT06730932
This is an open-label phase Ib/II clinical study to evaluate the safety, to...
Status
Completed
Location
Shanghai Chest Hospital
Start Date
2023-02-09
Trial ID
NCT05664971
The Study is a Phase 3, randomized, three-arm, double-blind, placebo-contro...
Status
Recruiting
Location
Harbin Medical University Cancer Hospital
Start Date
2023-11-15
Trial ID
NCT06095583
Treatments Being Tested